Cargando…
Empagliflozin increases kidney weight due to increased cell size in the proximal tubule S3 segment and the collecting duct
The inhibition of renal SGLT2 glucose reabsorption has proven its therapeutic efficacy in chronic kidney disease. SGLT2 inhibitors (SGLTi) have been intensively studied in rodent models to identify the mechanisms of SGLT2i-mediated nephroprotection. So far, the overwhelming effects from clinical tri...
Autores principales: | Sinha, Frederick, Federlein, Anna, Biesold, Annika, Schwarzfischer, Magdalena, Krieger, Katharina, Schweda, Frank, Tauber, Philipp |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10076569/ https://www.ncbi.nlm.nih.gov/pubmed/37033639 http://dx.doi.org/10.3389/fphar.2023.1118358 |
Ejemplares similares
-
Empagliflozin Reduces Renal Hyperfiltration in Response to Uninephrectomy, but Is Not Nephroprotective in UNx/DOCA/Salt Mouse Models
por: Tauber, Philipp, et al.
Publicado: (2021) -
Viewing Cortical Collecting Duct Function Through Phenotype-guided Single-Tubule Proteomics
por: Himmerkus, Nina, et al.
Publicado: (2020) -
Functionally induced changes in water transport in the proximal tubule segment of rat kidneys
por: Faarup, Poul, et al.
Publicado: (2011) -
Phosphatidylinositol metabolism of the renal proximal tubule S3 segment is disturbed in response to diabetes
por: Rietjens, Rosalie G. J., et al.
Publicado: (2023) -
Increased mitochondrial activity in renal proximal tubule cells from young spontaneously hypertensive rats
por: Lee, Hewang, et al.
Publicado: (2013)